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  Receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis is accompanied by intra-
cellular Ca2＋ mobilization in a form of oscillations, which plays essential roles by activating sequen-
tially Ca2＋ /calmodulin-dependent protein kinase, calcineurin and NFATc1, necessary in the osteoclast 
differentiation. However, it is not known whether Ca2＋ mobilization which is evoked in RANKL-in-
dependent way induces to differentiate into osteoclasts. In present study, we investigated Ca2＋ 
mobilization induced by aluminum fluoride (AlF4−), a G-protein activator, with or without RANKL 
and the effects of AlF4− on the osteoclastogenesis in primary cultured mouse bone marrow-derived 
macrophages (BMMs). We show here that AlF4− induces intracellular Ca2＋ concentration ([Ca2＋]i) 
oscillations, which is dependent on extracellular Ca2＋ influx. Notably, co-stimulation of AlF4− with 
RANKL resulted in enhanced NFATc1 expression and formation of tartrate-resistant acid phosphatase 
(TRAP) positive multinucleated cells. Additionally, we confirmed that mitogen-activated protein kinase 
(MAPK) is also activated by AlF4−. Taken together, these results demonstrate that G-protein would 
be a novel modulator responsible for [Ca2＋]i oscillations and MAPK activation which lead to 
enhancement of RANKL-mediated osteoclastogenesis.
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INTRODUCTION
  Receptor activator of NF-κB ligand (RANKL) expressed 
from osteoblasts binds to its own receptor, RANK, in osteo-
clast precursor cells, bone marrow-derived macrophage 
(BMMs), and initiates osteoclastogenesis by activating vari-
ous intracellular signal pathways including mitogen-acti-
vated protein kinases (MAPKs), NF-κB, AP-1, c-fos, and 
NFATc1 [1-5]. Among them, NFATc1, which is regarded as 
a key factor to determines the late-stage of differentiation 
to osteoclast, is well defined to be modulated by intra-
cellular Ca2＋ mobilization [3]. According to previous reports 
including ours, RANKL generates intracellular Ca2＋ mobi-
lization via co-stimulatory signals mediated through im-
munoreceptor tyrosine-based activation motif (ITAM)-har-
bouring adaptors, such as Fc receptor common γ subunit 
(FcRγ) and DNAX-activating protein (DAP) 12 and reactive 
oxygen species (ROS) generation. RANKL-mediated intra-
cellular Ca2＋ mobilization is presented in a form of oscil-
lations which needs Ca2＋ flux into cytoplasm from both ex-
ternal and internal Ca2＋ stores to form and sustain oscil-
lation frequencies that is essential for sequential activation 
of Ca2＋/calmodulin-dependent kinase, calcineurin, and 
NFATc1 [6,7]. In contrast, it has not been reported that 
Ca2＋ mobilization generated by RANKL-independent way 
affects on differentiation into osteoclast. 
  Diverse signal pathways mediated by G-protein coupled 
receptors (GPCR) is reported to be involved in various os-
teogenic activities including cell survival, tumorigenesis, 
and differentiation of osteoclast [8-12]. For example, ovar-
ian cancer G protein-coupled receptor 1 (OGR1) activated 
by protons or lysolipids modulates not only osteoclast sur-
vival through NFAT-independent but also osteoclasto-
genesis through an OGR1/NFAT pathway [8,11]. Notably, 
regulator of G-protein signaling (RGS) 18, which is known 
to act as a GTPase activating protein (GAP), negatively reg-
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ulates osteoclastogenesis by modulating the activity of Gα 
subunit [11]. Here an important question has arisen wheth-
er modulating the activity of Gα subunit alone affects on 
the RANKL-induced Ca2＋ oscillations and osteoclastoge-
nesis.
  Aluminum-fluoride complex (AlF4−) act as an analog of 
a phosphate group and stimulates cellular heteromeric 
G-proteins because of its structural similarity with phos-
phate group. AlF4− is tetrahedral and its Al-F bond length 
is very similar to P-O bond length of phosphate [13]. AlF4− 
can be used as useful tools investigating signal pathways 
following G-proteins. AlF4− stimulates G-protein and mim-
ics the action of many neurotransmitters, hormones, and 
immune system [13,14]. AlF4−-induced Ca2＋ oscillations 
were showed in smooth muscle cell [15] and pancreatic aci-
nar cells [16]. AlF4− is also known to transmit signals mod-
ulating activities of bone cells, such as cell proliferation, 
differentiation [17] and protein phosphorylation [18]. It was 
reported that the effects of fluoride and aluminum on levels 
of the second messenger molecules are dependent on the 
type of cells and tissues [13]. Along with these reports, we 
postulated that induced Ca2＋ signaling by aluminum-fluo-
ride complexes may affect osteoclast differentiation, and 
the investigation was undertaken to study the effects of 
AlF4− on Ca2＋ signaling and osteoclasts differentiation in 
primary cultured mouse bone marrow-derived macrophages 
(BMMs). In this study, we demonstrate that co-stimulation 
of AlF4− with RANKL has synergistic effects enhancing 
RANKL-induced Ca2＋ oscillations, NFATc1 expression, and 
forming multinucleated cells (MNCs).
METHODS
Chemicals and antibodies
  Recombinant mouse soluble RANK ligand and recombi-
nant mouse M-CSF were purchased from KOMA Biotech 
(Seoul, Korea). AlCl3 and NaF were purchased from Sigma 
Aldrich (St. Louis, MO, USA) and Fluka (Buchs, Switzer-
land) respectively. Fura-2/AM was purchased from Teflabs 
(Austin, TX, USA). Pluronic F-127 was obtained from 
Invitrogen (Eugene, Oregon, USA). Monoclonal antibodies 
against ERK, phospho-ERK, JNK and phospho-JNK were 
purchased from Cell Signaling (Danvers, MA, USA); poly-
clonal antibody for NFATc1 was from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). 
Cell culture
  Non-adherent bone marrow-derived macrophages (BMMs) 
were isolated from tibia and femur of 4-week-old male ICR 
mice (weight 21∼25 g) as described previously [19]. Briefly, 
isolated BMMs were cultured in α-minimum essential me-
dium (α-MEM; Gibco/BRL, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum (FBS; Gibco/BRL, Grand 
Island, NY, USA) in the presence of M-CSF (20 ng/ml).
Intracellular Ca2＋ imaging
  The cells were seeded on cover glass in a 35-mm dish 
(1×105 per dish) and treated with RANKL (50 ng/ml) and/or 
aluminum-fluoride complex (1.25 mM NaF＋25 nM AlCl3). 
Cells were loaded with 3 μM fura-2/AM, 0.05% Pluronic 
F-127 in an extracellular physiological salt solution (140 
mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM 
HEPES, and 10 mM glucose, titrated to pH 7.4 with NaOH. 
The osmolarity of the PSS was 310 mOsm) at room temper-
ature and washed out with standard solution. [Ca2＋]i was 
measured using wave lengths of 340 and 380 nm, and the 
emitted light was passed through a 510 nm cut off filter 
and was collected with a CCD camera and analyzed with 
a Meta Fluor system (Universal Imaging Co., Downing-
town, PA, USA). The 340/380 fura-2 ratio was taken as a 
measure of [Ca2＋]i and fluorescence images were obtained 
at 2s intervals. Images were digitized and analyzed through 
MetaFluor software (Universal Imaging).
In vitro osteoclastogenesis and TRAP staining
  RANKL (50 ng/ml) and/or AlF4− (1.25 mM NaF＋25 nM 
AlCl3) were added to BMMs (2×105 per well) cultured in 
24-well plate with α-MEM containing M-CSF (20 ng/ml). 
Six days later osteoclastogenesis was confirmed by TRAP 
(tartrate-resistant acid phosphatase) staining to evaluate 
TRAP-positive multinucleated osteoclast formation. Naph-
thol AS-MX (Amresco, Cleveland, OH, USA) was used as 
the substrate and fast red violet LB salt (Sigma Aldrich, 
St. Louis, MO, USA) as the diazonium salt. TRAP＋ multi-
nucleated cells (≥3 nuclei) were counted.
Immunocytochemistry
  Cells seeded on 12-mm cover glasses were treated with 
RANKL (50 ng/ml) and/or AlF4− (1.25 mM NaF＋25 nM 
AlCl3). After fixation with 10% methanol at −20oC for 10 
min, cells were washed with cold phosphate buffered saline 
(PBS) and neutralized with 50 mM Glycine for 10 min at 
4oC. Cells were sequentially blocked with 5% goat serum 
in incubation buffer (0.1% gelatin, 1% BSA, 0.01% sodium 
azide in PBS) and stained with 1 drop of 200 U/ml phalloi-
din in the dark for 1 hr. And then, cells were washed with 
cold PBS. 
Western blot
  Whole cell extracts of BMMs were prepared by washing 
the cells with cold PBS and lysed in RIPA buffer (20 mM 
Tris, pH 7.4, 250 mM NaCl, 2 mM EDTA, pH 8.0, 0.1% 
Triton-X100, 0.01 mg/ml aprotinin, 0.005 mg/ml leupeptin, 
0.4 mM PMSF, and 4 mM NaVO4) for 30 min. 20 μg/well 
proteins were loaded on 10% SDS-PAGE respectively, and 
then were separated by size. Separated proteins were trans-
ferred onto nitrocellulose membranes, blocked with 5% BSA 
in TBS, and probed with Abs against phospho-ERK (1：
1,000), total-ERK (1：1,000), phospho-JNK (1：1,000), to-
tal-JNK (1：1,000), NFATc1 (1：1,000) and β-actin (1：
1,000) for overnight. After washing out, the blots were in-
cubated with HRP-conjugated secondary antibodies for 1 
hr, and visualized by enhanced chemiluminescence (ECL, 
Amersham Pharmacia Biotech, IL, USA) using Agfa CP-BU 
new film (Mortsel, Belgium). The level of protein expression 
was digitized film images and analyzed with MetaMorph 
software (Universal Imaging).
Statistical analysis
  Results are expressed as means±S.E. from at least 3 in-
dependent experiments. The statistical significances of dif-
ferences between groups were determined using the Stu-
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Fig. 2. Increased expression of NFAT-
c1 in BMMs induced by RANKL and 
AlF4−. Whole cells lysates were collec-
ted from cells stimulated with RANKL 
and/or AlF4− for indicated time. 
NFATc1 and actin were blotted with 
its antibody (upper panels) and then 
showed means of protein expression 
levels between RANKL and AlF4−
(lower panels). Expression level was 
significantly increased for NFATc1 in 
48 h and 72 h of RANKL and AlF4−
treatments (n=3). Data were expres-
sed as the mean±SEM. **p＜0.01, 
***p＜0.001 compared with RANKL 
treated group.
Fig. 1. Effects of the [Ca2＋]i increa-
ses mediated by RANKL and AlF4− in 
BMMs. BMMs were treated with 
RANKL (50 ng/ml) and/or AlF4− (1.25 
mM NaF＋25 nM AlCl3). After 48 h of 
the stimulations, [Ca2＋]i oscillations 
in BMMs were measured using Fura-2 
fluorescence dye. Compared to RANKL 
alone, application of AlF4− similarly 
increased frequency of the [Ca2＋]i
oscillations in the presence or absence 
of RANKL (left panels). These induc-
tion of [Ca2＋]i oscillations were dimi-
nished by the removal of extracellular 
Ca2＋ (right panel).
dent t-test. The difference is significant if the value is 
＜0.05.
RESULTS
Treatment of AlF4− induces Ca2＋ mobilization similar 
to RANKL-induced [Ca2＋]i oscillation
  We have previously reported that RANKL stimulation on 
BMMs induces [Ca2＋]i oscillations which is dependent on 
Ca2＋ flux from both external and internal store [6]. To de-
termine whether direct activation of G-protein by AlF4− 
would affect on the intracellular Ca2＋ mobilizations, we an-
alyzed AlF4−-mediated Ca2＋ responses in the presence or 
absence of RANKL. As shown in Fig. 1, [Ca2＋]i oscillations, 
which is dependent on extracellular Ca2＋ influx, were ob-
served from 24 to 48 hrs after RANKL treatment in BMMs 
(Fig. 1, upper panel). Notably, co-stimulation with AlF4− 
and RANKL (Fig. 1, middle panel) and AlF4− treatment 
alone (Fig. 1, lower panel) led to increase of oscillations fre-
quency in comparison to RANKL alone, suggesting that 
G-protein activation would amplify the RANKL-mediated sig-
nals and be enough to induce [Ca2＋]i oscillations regardless 
of the presence of RANKL. Furthermore, these all [Ca2＋]i os-
cillations presented dependency on extracellular Ca2＋ 
influx. Along with these results, we could assumed that 
[Ca2＋]i oscillations caused by AlF4− has similar character-
istics with the one caused by RANKL. Moreover, AlF4− is 
capable to not only induce [Ca2＋]i oscillations which has 
similar characteristics with RANKL-induced [Ca2＋]i oscil-
lations but also enhance it.
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Fig. 3. RANKL and AlF4−-induced osteoclast differentiation in BMMs. (A) To confirm the formation of multinucleated cells (MNCs, number 
of nuclear＞3), each sample was incubated for 6 days in (a) control and the presence of (b) RANKL, (c) RANKL and AlF4−, and (d) 
AlF4−. TRAP staining was performed as described in methods. And then MNCs in each well was counted (n=3, scale bar, 50 μm). 
Application of RANKL and AlF4− in BMMs was significantly increased rates of TRAP＋ MNCs formation more than the application 
of RANKL alone (lower panel). (B) Actin staining of TRAP＋ MNCs in application of RANKL and AlF4− was similarly showed normal 
actin ring formations during osteoclastogenesis compared to RANKL treated BMM cells. Bar graph shows relative MNCs of BMMs treated
with RANKL only and RANKL＋ AlF4−. Data were normalized to the number of MNCs in RANKL treated BMMs and expressed as 
the mean±SEM. *p＜0.05 compared with RANKL treated group.
Co-stimulation with AlF4− and RANKL enhances 
NFATc1 expression, but not AlF4− alone
  NFATc1 is known to be up-regulated by RANKL stim-
ulation and modulates cell fusion and maturation [3]. As 
described previously, we found that AlF4− solely induces 
intracellular Ca2＋ mobilization in a form of oscillations 
which has similar characteristics with RANKL-induced 
[Ca2＋]i oscillations. However, it is not clear that AlF4−- 
mediated [Ca2＋]i oscillations is sufficient to transmit sig-
nals related on the differentiation to osteoclasts. To answer 
this question, we employed a standard in vitro osteoclast 
culture system and prepared whole cell lysates from cells 
maintained with M-CSF and RANKL in the presence or ab-
sence of AlF4−. As shown in Fig. 2, similar tendency of the 
NFATc1 induction was observed in both samples treated 
with RANKL alone and both of RANKL and AlF4−, which 
starts to be increased from 24 hrs and maximized around 
48 hrs after stimulation. Whereas, in terms of quantity of 
expression, co-stimulation with RANKL and AlF4− more 
than 48 hrs resulted in 1.7-fold increase compared to 
RANKL alone. Unlike our expectation, sole treatment of 
AlF4− did not induce NFATc1 expression. 
Co-stimulation with AlF4− and RANKL enhances the 
formation of TRAP-positive multinucleated cells, but 
not AlF4− alone
  To further investigate the effects of AlF4− on RANKL-in-
duced osteoclastogenesis, we examined the effects of en-
hanced [Ca2＋]i oscillations by AlF4− on the formation of 
MNCs and actin ring. BMMs were stimulated with AlF4− 
(1.25 mM NaF＋25 nM AlCl3) in the presence or absence 
of RANKL (50 ng/ml) for 6 days, and TRAP and phalloidin 
staining were conducted. Interestingly, TRAP＋ MNCs were 
only confirmed in RANKL treated cells, but not in the cells 
with only AlF4− (Fig. 3A). However, BMMs treated with 
AlF4− and RANKL simultaneously showed remarkably en-
hanced MNCs formation (Fig. 3A). Consistent with TRAP 
staining results, we also confirmed that co-stimulation with 
AlF4− and RANKL increased actin ring formation compared 
to RANKL alone (Fig. 3B), but not in AlF4− alone. These 
results suggest that AlF4−-mediated signals are not suffi-
cient for cell fusion and attachment but it improves osteo-
clastogenesis when it coexists with RANKL. 
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Fig. 4. Phosphorylation of MAPK in 
BMMs induced by RANKL and AlF4−. 
To confirm the phosphorylation of 
MAPK in response of RANKL and/or 
AlF4−, ERK and JNK were blotted 
with its antibody. Applications of 
RANKL and/or AlF4− in BMMs were 
induced phosphorylation of ERK and 
JNK in a time-dependent manner. 
Induction of MAPK signal pathway in response to 
AlF4− 
  RANKL is also known to transmit signals through activa-
tion of MAPK pathway including ERK, JNK, and AP-1 cru-
cial for gene expression by clustering with CREB, MITF, 
PU.1, and NFATc1 [20-23]. To gain insight of G-protein ac-
tivation into MAPK pathway, we measured phosphor-
ylation of ERK and JNK in response of RANKL and both 
of RANKL and AlF4−. To confirm this, western blot analysis 
was performed on lysates of BMMs incubated with RANKL 
(50 ng/ml) and/or AlF4− (25 nM AlCl3＋1.25 mM NaF) in 
a time-dependent manner. We could observe phosphor-
ylation of ERK and JNK in response of RANKL, as reported 
previously, and both of RANKL and AlF4− (Fig. 4). Interes-
tingly, phosphorylation of ERK and JNK was also detected 
in only AlF4− treated sample, suggesting that activation of 
G-protein is somehow directly related with MAPK. Taken 
together, these results clearly indicate that activation of 
G-protein synergistically improve RANKL-mediated osteo-
clastogenesis through enhancing Ca2＋ oscillations and 
MAPK pathway.
DISCUSSION 
  Diverse Ca2＋ signals in osteoclast are essential for cel-
lular functions including motility, differentiation, and bone 
resorption [6,8-10]. Several reports including ours clearly 
presents that RANKL-induced [Ca2＋]i oscillation occurred 
by activation of phospholipase C (PLC) and IP3 production, 
which evokes Ca2＋ release from the ER, resulting in in-
duction of Ca2＋ oscillations. There are numerous hormones 
and neurotransmitters which lead to intracellular Ca2＋ mo-
bilization relied on sequential activation of GPCR, G-pro-
tein, and PLC [24,25]. Recent studies showed specific 
GPCRs are involved in osteoclastogenesis and deficiency of 
RGS impairs to differentiate into osteoclast due to the ab-
sence of Ca2＋ signaling [26]. Inspired by these, we assumed 
that activation of G-protein by itself may be sufficient or 
necessary for the differentiation into osteoclast regardless 
of RANKL stimulation. Under this hypothesis, we first con-
firmed that sole activation of G-protein generates [Ca2＋]i 
oscillations using AlCl3 and NaF because traces of aluminum 
can form aluminum-fluoride complex (most likely AlF4−) 
easily in aqueous solutions [13] and makes a synergistic 
action of fluoride to activate G-proteins [27]. AlF4− is well 
known to directly activate a GTP-binding protein coupled 
to PLC [28]. Interestingly, we observed that not only 
co-stimulation with RANKL and AlF4− but also AlF4− alone 
induce [Ca2＋]i oscillations in both BMMs. However, we 
could not see any Ca2＋ responses when the same concen-
tration of AlF4− was treated acutely. Moreover, as our pre-
vious report, we also confirmed that extracellular Ca2＋ in-
flux is crucial for sustained [Ca2＋]i oscillations in response 
to AlF4− alone and both of RANKL and AlF4−, clearly pre-
senting that AlF4−-induced [Ca2＋]i oscillations is generated 
through similar mechanism with RANKL’s. The character-
istic of intracellular Ca2＋ signaling varies as following sig-
nal molecules, which gives diversity and versatility on the 
cell functions [29]. Based on our results, it is assumed that 
activation of G-protein by AlF4− possibly determines cell 
fate of BMMs alike with RANKL.
  To further investigate physiological phenomenon induced 
by AlF4− or co-stimulation with RANKL and AlF4−, we de-
cided to check NFATc1 activity and the formation of TRAP＋ 
MNCs and actin ring, which are widely used as a criterion 
to confirm the osteoclastogenesis. Intriguingly, results from 
immunoblotting for NFATc1, TRAP staining, and im-
munostaining for actin revealed that activation of G-protein 
mediated by AlF4− in the absence of RANKL is not suffi-
cient to differentiate to osteoclast. On the other hand, re-
markable enhancement of NFATc1 expression, and for-
mation of MNCs and actin ring in cells treated with 
RANKL and AlF4− simultaneously was identified. These re-
sults strongly suggest that activation of G-protein by AlF4− 
acts as a synergic factor that somehow interacts with 
RANKL-mediated other signals responsible for trans-
mitting differentiation-related signals to downstream. Our 
results raise an important question of which Gα subunit 
is activated and causes the enhancement of osteoclas-
togenesis. There are the major four families, Gαq/11, Gαs, 
Gαi, and Gα12/13 whose main effector molecules are thought 
to be PLC, adenyly cyclase, and small GTPase families [30]. 
Following studies support the involvement of Gα subunits 
including Gαq/11, Gαs, and Gαi in osteoclastogenesis. OGR1, 
which is one of GPCR coupled to Gαq/11 and triggers [Ca2＋]i 
mobilization, is reported to be involved in RANKL-induced 
osteoclastogenesis by modulating NFATc1 signaling path-
way [11,12,31]. Continuous production of cAMP mediated 
by dopamine D1-like receptor, which is coupled to Gαs sub-
unit, contributes to RANKL-induced osteoclastogenesis, 
whereas activation of dopamine D2-like receptor, which is 
coupled to Gαi subunit and inhibits adenylyl cyclase, sup-
presses RANKL-induced osteoclastogenesis [32]. Further-
more, critical role of CREB (cAMP response element bind-
ing protein) in RANKL-mediated osteoclastogenesis strong-
ly supports that finely tuned cAMP production by Gαs and 
Gαi and Gαq/PLC/IP3/Ca2＋ signaling pathway are a key 
modulator in osteoclastogenesis [25,33,34]. Taken together, 
it is convinced that modulating the activities of Gαq/11, Gαs 
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and Gαi affects on RANKL-induced osteoclastogenesis. 
Since our current results clearly show that treatment of 
AlF4− induces [Ca2＋]i mobilization in a form of oscillations 
and enhances RANKL-mediated osteoclastogenesis, Gαq/11 
seems to dominantly be involved in RANKL-mediated 
osteoclastogenesis. However, due to the property of AlF4− 
as a universal activator of Gα subunit, it should be another 
important study to determine which subtype of Gα subunit 
governs signaling pathway related to differentiation.
  Before the finding of co-stimulatory signal pathway in-
cluding Ca2＋ increase via DAP12 and FcRγ, it is generally 
accepted that TRAF6/MAPK/AP-1/NFATc1 pathway main-
ly dominates gene induction responsible for late-stage of os-
teoclastogenesis [2,35,36]. As shown in Fig. 4, RANKL is 
known to activate MAPK pathway, such as ERK and JNK, 
at early moment. Consistent with previous results, activa-
tion of ERK and JNK is appeared to be activated in re-
sponse to not only co-stimulation with RANKL and AlF4− 
but also AlF4− alone. Although this result bring puzzling 
question that is subject to different interpretations with re-
spect to the cause-effect relationship between [Ca2＋]i oscil-
lations and MAPK, we could assure that AlF4− is sufficient 
to activate MAPK necessary for osteoclastogenesis. One of 
important finding in this result is that function of G-protein 
responsible for differentiation into osteoclast is associated 
with either pathway of Ca2＋ mobilization and MAPK by 
which enhance cell fusion and attachment of cell on bone 
surface. The role of GPCR in osteoclastogenesis is still un-
certain though there are several reports showing involve-
ment of signal molecules following GPCR activation in 
osteoclastogenesis. The other is the application of AlF4− for 
inducing various cell functions by activating G-protein. AlF4− 
acts as a messenger of false information [13] and have been 
often used in many laboratories to investigate their effects 
on various cells and tissues. Further studies are needed to 
clarify the potential risks for human health of long-term 
exposure to AlF4−. Notably, our study indicates the possi-
bility that Gα subunits can be regarded as a target mole-
cule necessary on modulating bone resorption. As men-
tioned previously, OGR1 (GPR68), which is coupled to Gαq/11 
subunit and transmit signals to PLC, is one of few GPCRs 
that is demonstrated the roles in osteoclastogenesis. Des-
pite of the absence of direct evidence, following studies pre-
sented the answer for the question. 1) Deficiency of OGR1 
caused abnormalities in osteoclastogenesis [9], 2) RGS18, 
which accelerates intrinsic GTP hydrolysis on hetero-
trimeric G-protein alpha subunits, negatively regulates os-
teoclastogenesis by modulating OGR1/NFAT signaling 
pathway [11]. Unless RANKL directly activates Gα sub-
units, inhibition of G alpha subunits may not block the 
osteoclastogenesis. However, assuming Gα subunits is in-
hibited in vivo, it can cause the reduction of osteoclasto-
genesis and bone resorption.
  In summary, present study demonstrates that AlF4− in-
duces [Ca2＋]i oscillations and MAPK, which lead to improve 
RANKL-mediated osteoclastogenesis by enhancing NFATc1 
expression. Although not described in detail here, it is need-
ed that further verification for signal molecules related 
with G-protein, such as GPCR and RGS protein, during 
osteoclastogenesis. With this finding, it should be a novel 
therapeutic target for bone-related disorders including os-
teoporosis and osteopetrosis. 
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